Farfel Gail M
SEC-identified person · CIK 1614780 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Durect Corp DRRX | Director | filed 2019 - 2025 |
| Promis Neurosciences Inc. PMN | Director · Chief Executive Officer | filed 2022 - 2023 |
| Tectonic Therapeutic, Inc. TECX | Director | filed 2020 - 2023 |
| Zogenix, INC. ZGNX | See Remarks | filed 2015 - 2022 |
| Marinus Pharmaceuticals, INC. NASDAQMRNS | Chief Clinical Dev.Regulatory | filed 2014 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.